Table 3.

Intraoperative and Postoperative Treatment of BP in Patients With CSTs (N=10)

Study Variables	Frequency
Intra‐operative hypertension	3 (30%)
Labetalol infusion, (n)	1
Duration, (hours)	2
Sodium nitroprusside infusion, (n)	1
Duration, (hours)	1.5
Esmolol infusion, (n)	1
Duration, (hours)	1.5
Intra‐operative hypotension	2 (20%)
Albumin infusion, (n)	2
PRBC infusion, (n)	2
Vasopressor medication infusion, (n)	1
Duration, (hours)	1
Intra‐operative hypertension and hypotension	5 (50%)
Sodium nitroprusside infusion, (n)	3
Duration, (hours)	0.6
Esmolol infusion, (n)	2
Duration, (hours)	1
Albumin infusion, (n)	4
PRBC infusion, (n)	1
Vasopressor medication infusion, (n)	1
Duration, (hours)	0.5
Postoperative hypertension	2 (20%)
Oral anti‐hypertensives, (n)	2
Postoperative hypotension	2 (20%)
Crystalloid infusion, (n)	1
Vasopressor medication infusion, (n)	2
Duration <24 hours	2
Discontinuation of all BP medications, (n)	10 (100%)
Immediate post‐op period	6
1–4 days	2
>4 days	2

Abbreviations: BP, blood pressure; CSTs, catecholamine‐secreting tumors; PRBC, packed red blood cell.